Promethera Therapeutics

Promethera Therapeutics is pioneering the development of cutting-edge cell-based therapies for the treatment of liver to reduce the need for transplantation.

Industries

Biotechnology

Headquarters

Mont-Saint-Guibert, Belgium

Stage

Series D

Employees

51-200

Links

Org chart

Etienne Sokal MD PhD

President & CEO

Collapse

Mustapha Najimi PhD

Chief Scientific Officer

Bruno De Keersmaeker

Finance Director

Eric Pauly

VP Operations/CMC

Virginie Barthel

Director Clinical Operations

Teams

View all

Board of Directors

6 members

Leadership Team

5 members

CEO and Executive Team

2 members

Discover similar companies

Celyad

Mont-Saint-Guibert, Belgium · Post IPO Equity

Applied StemCell

Milpitas, United States · Series D

AnaptysBio

San Diego, United States · IPO

Kallyope

New York, United States · Grant

Mammoth Biosciences

Brisbane, United States · Series D

Biofourmis

Boston, United States · Series D

Ecovative Design

Green Island, United States · Series D

ViaCyte

San Diego, United States · Series D

Akoya Biosciences

San Francisco, United States · Series D

Century Therapeutics

Philadelphia, United States · Post IPO Equity

Maze Therapeutics

South San Francisco, United States · Venture

Passage Bio

Philadelphia, United States · Post IPO Equity

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.